HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $510 Price Target

Alnylam Pharmaceuticals, Inc -0.60% Pre

Alnylam Pharmaceuticals, Inc

ALNY

320.43

320.43

-0.60%

0.00% Pre
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Buy and maintains $510 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via